T-cell immunoglobulin and mucin-domain containing-3 in malignant cancers

被引:2
|
作者
Xu, Yun [1 ]
Jiang, Xiping [1 ]
Huang, Yaqing [1 ]
机构
[1] Soochow Univ, Affiliated Hosp 3, Dept Gynecol, 185 Juqian St, Changzhou 213003, Peoples R China
关键词
T-cell immunoglobulin and mucin-domain containing-3 (Tim-3); human cancer; anti-Tim-3; antibody; cancer immunotherapy; 3 GENE POLYMORPHISMS; TIM-3; EXPRESSION; UP-REGULATION; THERAPEUTIC TARGET; POOR-PROGNOSIS; MELANOMA-CELLS; PD-1; DYSFUNCTION; ACTIVATION; EXHAUSTION;
D O I
10.21037/tcr.2017.05.08
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Immune checkpoints are one of the key factors comprising the extensive network of the human immune system. Immune checkpoints ensure T-cell homeostasis, activation and differentiation. The checkpoint T-cell immunoglobulin and mucin-domain containing-3 (Tim-3) plays an important role in immune system. Tim-3 is a member of TIM family and can negatively regulate T helper 1 (Th1) immunity. A literature search for Tim-3 was performed via PubMed. It is suggested that the overexpression of Tim-3 is correlated with poorer prognosis for multiple cancers. Co-expression of Tim-3 and other immune checkpoints has been revealed. Blockade of Tim-3 exerts antitumor function and may have synergistic activity being alone or combined with anti-PD-1 antibody or chemotherapy. Thus, Tim-3 is a promising target for cancer immunotherapy.
引用
收藏
页码:613 / 619
页数:7
相关论文
共 50 条
  • [1] T cell immunoglobulin and mucin-domain containing-3 in non-small cell lung cancer
    Jia, Keyi
    He, Yayi
    Dziadziuszko, Rafal
    Zhao, Sha
    Zhang, Xiaoshen
    Deng, Juan
    Wang, Hao
    Hirsch, Fred R.
    Zhou, Caicun
    Yu, Hui
    Zhang, Liping
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (06) : 895 - +
  • [2] The prospect of targeting T cell immunoglobulin and mucin-domain containing-3 in renal cell carcinoma immunotherapy
    Mohsenzadegan, Monireh
    Nowroozi, Mohammad Reza
    Fotovvat, Amirreza
    Bavandpour Baghshahi, Parizad
    Bokaie, Saied
    Inanloo, Seyed Hassan
    Sharifi, Laleh
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2022, 96 (03)
  • [3] T-cell immunoglobulin and mucin-domain containing-3 (TIM-3): Solving a key puzzle in autoimmune diseases
    Chen, Huihui
    Zha, Jie
    Tang, Runyan
    Chen, Guochun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 121
  • [4] Upregulation of T-cell Immunoglobulin and Mucin-Domain Containing-3 (Tim-3) in Monocytes/Macrophages Associates with Gastric Cancer Progression
    Wang, Zhenxin
    Yin, Ni
    Zhang, Zixiang
    Zhang, Yi
    Zhang, Guangbo
    Chen, Weichang
    IMMUNOLOGICAL INVESTIGATIONS, 2017, 46 (02) : 134 - 148
  • [5] The Potential of T Cell Immunoglobulin and Mucin-Domain Containing-3 (Tim-3) in Designing Novel Immunotherapy for Bladder Cancer
    Mohsenzadegan, Monireh
    Bavandpour, Parizad
    Nowroozi, Mohammad Reza
    Amini, Erfan
    Kourosh-Arami, Masoumeh
    Momeni, Seyed Ali
    Bokaie, Saied
    Sharifi, Laleh
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2021, 21 (12) : 2131 - 2146
  • [6] Structure and Functions of T-cell Immunoglobulin-domain and Mucin-domain Protein 3 in Cancer
    Lu, Xinjie
    CURRENT MEDICINAL CHEMISTRY, 2022, 29 (11) : 1851 - 1865
  • [7] Prognostic value of T cell immunoglobulin and mucin-domain containing-3 expression in upper gastrointestinal tract tumors: A meta-analysis
    Yan, Jing-Jing
    Liu, Bing-Bing
    Yang, Yan
    Liu, Meng-Ru
    Wang, Han
    Deng, Zhen-Quan
    Zhang, Zhi-Wei
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 15 (12)
  • [8] T-cell immunoglobulin and mucin-domain containing protein (TIM) structural dynamics revealed by molecular dynamics simulations
    Rosenfeld, Mia A.
    Kearns, Fiona L.
    Chongsaritsinsuk, Joan
    Steigmeyer, Alexandra
    Mahoney, Kiera E.
    Lucas, Taryn
    Ince, Deniz
    Battison, Alexandria
    Hollenhorst, Marie A.
    Shon, D. Judy
    Attah, Victor
    Kwon, Catherine
    Bertozzi, Carolyn R.
    Malaker, Stacy A.
    Amaro, Rommie E.
    BIOPHYSICAL JOURNAL, 2023, 122 (03) : 204A - 204A
  • [9] Serum Levels of T Cell Immunoglobulin and Mucin-Domain Containing Molecule 3 in Patients with Systemic Lupus Erythematosus
    Asano, Tomoyuki
    Matsuoka, Naoki
    Fujita, Yuya
    Matsumoto, Haruki
    Temmoku, Jumpei
    Yashiro-Furuya, Makiko
    Sato, Shuzo
    Suzuki, Eiji
    Kobayashi, Hiroko
    Watanabe, Hiroshi
    Migita, Kiyoshi
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 9
  • [10] T cell immunoglobulin and mucin-domain containing-3 (TIM-3), lymphocyte-activation gene 3 (LAG-3), and T cell immunoreceptor with immunoglobulin and ITIM domain (TIGIT) - an update on emerging negative immune checkpoints in cancer treatment
    Krzyzanowska, Natalia
    ONCOLOGY IN CLINICAL PRACTICE, 2025,